Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
The COVID-19 pandemic is an ongoing global pandemic of coronavirus disease 2019 as an atypical type of viral pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many potential pharmacotherapies are currently being investigated against this disease. This article points t...
Saved in:
Main Authors: | Amani E. Khalifa, PhD (Author), Asser I. Ghoneim, PhD, PharmD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Toll-Like Receptors (TLR) in Infection and Inflammation
Published: (2023) -
TLR10: An Intriguing Toll-Like Receptor with Many Unanswered Questions
by: Carolina Rego Rodrigues, et al.
Published: (2024) -
Classification, Mechanisms of Action, and Therapeutic Applications of Inhibitory Oligonucleotides for Toll-Like Receptors (TLR) 7 and 9
by: Petar S. Lenert
Published: (2010) -
Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease
by: Haleh Vaez, et al.
Published: (2023) -
Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease
by: Wenbin Dai, et al.
Published: (2022)